Screener
AbCellera Biologics Inc. ABCL Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | Three months ended June 30, 2025 | Three months ended June 30, 2026 | Six months ended June 30, 2025 | Six months ended June 30, 2026 |
|---|---|---|---|---|
| Grants and incentives | (3,692) | (3,854) | (7,845) | (8,193) |
| Total other income | (13,241) | (3,812) | (22,918) | (11,799) |
| Loss before income tax | (36,344) | (58,965) | (89,328) | (108,501) |
| Income tax recovery | (1,617) | (3,538) | (8,980) | (9,909) |
| Net loss | $(34,727) | $(55,427) | $(80,348) | $(98,592) |
| Foreign currency translation adjustment | 4,341 | (733) | 1,721 | 1,082 |
| Comprehensive loss | $(30,386) | $(56,160) | $(78,627) | $(97,510) |
| Net loss per share |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s income tax?
- AbCellera Biologics Inc. (ABCL) reported income tax of -$3.54M in Q2 2026.
- How has AbCellera Biologics Inc.'s income tax changed year-over-year?
- AbCellera Biologics Inc.'s income tax decreased by 118.8% year-over-year, from -$1.62M to -$3.54M.
- What is the long-term trend for AbCellera Biologics Inc.'s income tax?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s income tax has grown at a -17.0% compound annual growth rate (CAGR), from $65.69M to -$31.18M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about AbCellera Biologics Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude